1.Conception and strategy of building a digitized hospital customer service system
Chinese Journal of Hospital Administration 2012;28(5):364-367
Building a digitized and customer-oriented hospital customer service system is conducive to better service at the hospital.Such a system is an open customer service and management system,comprising digitized customer relation management and service platform,digital intelligent IVR customer service system,video interaction service system for hospital wards,IOT-based health management and service system,and 3G-based seamless pre-hospital and post-hospital green emergency rescue system,as well as other customer service systems including the outpatient auto-calling,self-service,information release,payment management,and IOT-based customer management system.By means of thorough customer analysis,automatic service trigger-off mechanism and considerate customer service,digitized hospital customer service system realized value of the hospital while providing the customers with valuable services.
2.COMBINED ASSAY OF SERUM TUMOR ENZYME MARKERS IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
Journal of Chongqing Medical University 1986;0(04):-
FDP/FIP (88.8%), respectively; (3) The diagnostic positivity of combination assay was 80.0% in low or negative AFP producing HCC, while 95.7% in those with elevated AFP. Our data suggested that the combination assay of serum tumor enzyme markers was valuable in the diagnosis of HCC, especially in low or negative AFP HCC patients
3.Clinical Research of Sexual Hormone Level of Vascular Dementia
Xiaodong SHEN ; Shuanghong SHEN
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(09):-
Objectives To investigate the relations between serum E2,T level and vascular dementia (VD) and therapy effect of Chinese medicine.Methods Seventy patients were selected and randomly divided into two groups:experimental group,which was treated with Chinese medicine and control group with western medicine.Results There was marked difference in E2 of female patient and E2,E2/T and T of male patient between experimental group and control group (P
4.Current status and advances in adjuvant therapy of operable breast cancer
China Oncology 1998;0(04):-
The widespread application of adjuvant therapy has shown clear benefits in the treatment of operable breast cancer. It is essential for the clinicians to select appropriate adjuvant regimens for this heterogeneous group of patients. Recent data from clinical trials evaluating the utility of adjuvant therapy were reviewed.
6.Efficacy and safety of ibutilide for conversion of atrial fibrillation
Chinese Journal of Primary Medicine and Pharmacy 2012;19(7):995-996
ObjectiveTo evaluate the efficacy and safety of ibutilide for conversion of paroxysmal and persistent atrial fibrillation.Methods31 patients with atrial fibrillation duration less than 90 days were included into amiodrone or ibutilide group.16 patients were intravenously administer with amiodrone and 15 patients with ibutilide separately.Conversion rate,time needed to converse and adverse effects were compared between two groups.ResultsThe total conversion rate of ibutilide group was significantly higher than that of amiodrone group (66.7% vs 37.5%,x2 =1.98,P < 0.05 ).Time needed to converse was significantly shortened in ibutilide group compared with amiodrone group [ ( 31.75 ± 7.39 ) min vs ( 51.87 ± 9.26 ) min,t =3.67,P < 0.05 ].No clinical significant adverse effects were observed in ibutilide group.ConclusionIntravenous administration of ibutilide in cardioversion of paroxysmal and persistent atrial fibrillation was more safe and effective than amiodrone.
7.The effect and safety of amlodipine besylate combined with benazepril in treatment of old patients with primary hypertension and left ventricular hypertrophy
Chinese Journal of Postgraduates of Medicine 2012;35(10):28-30
ObjectiveTo observe the effect of amlodipine besylate combined with benazepril in treatment of old patients with primary hypertension and left ventricular hypertrophy,and analyze the safety.MethodsOne hundred and eight old patients with primary hypertension and left ventricular hypertrophy were divided into observation group(54 cases) and control group(54 cases) by random digits table.The patients in observation group were treated with amlodipine besylate combined with benazepril and the patients in control group were only treated with amlodipine besylate.The levels of blood pressure,interventricular septal thickness(IVST),left ventricular posterior wall (LVPW),left ventricular end-diastolic dimension (LVEDD) and left ventficular mass index(LVMI) before and after treatment for 6 months were measured and compared between two groups.The adverse effects after treatment were compared too.ResultsAfter treatment,the levels of 24hSBP,24hDBP,IVST,LVPW,LVEDD and LVMI were significantly decreased in both groups (P < 0.05).Moreover,the levels of 24hSBP,24hDBP,IVST,LVPW,LVEDD and LVMI after treatment in observation group were significantly lower than those in control group(P < 0.05).There was 1 case ( 1.9% ) of dry cough,2 cases (3.7%) of mild ankle edema in observation group,while only 2 cases (3.7%) of mild ankle edema in control group.There was no significant difference in adverse effects between two groups (P > 0.05).ConclusionsCompared with amlodipine besylate single treatment,amlodipine besylate combined with benazepril in treatment of old patients with primary hypertension and left ventricular hypertrophy can more effectively control blood pressure and reverse left ventricular hypertrophy.The adverse effects are not increased,which can be applied in clinic.
8.The expression of AP-1 in pancreatic tumor cells
Chinese Journal of Primary Medicine and Pharmacy 2012;19(20):3060-3061
ObjectiveTo investigate the expression of AP-1 in pancreatic tumor cells and its clinical significance.MethodsSelected the paraffin-embedded specimens from the tumor tissues of 35 patients with pancreatic cancer(study group) and 35 pancreatic tissue of healthy people(control group),and double antibody sandwich ABCELISA detection of AP-1 was carried out,two sets of specimens C-JUN and C-FOS expression was observed.ResultsObservation group C-JUN and C-FOS expression positive rates were 80.00% 71.43%,control group,C-JUN and C-FOS expression positive rates were 22.86%,28.57%,there was a significant difference between the two groups.ConclusionAP-1 was highly expressed in pancreatic cancer,which could guide clinical take reasonable interventions to slow tumor development.
9.Practice of the compound medical insurance payment system under a ceiling control in Shenzhen
Chinese Journal of Hospital Administration 2012;28(10):785-788
The paper summarized the compound medical insurance payment system under a ceiling control with Shenzhen characteristics.This practice features ceiling control,prepaid at year beginning,multiple payment methods,monthly payment,year-end closing,and reward for surplus.The following measures have been implemented,namely controlling the total amount,compound payment mode,setting up the scientific and reasonable payment standards and establishing a perfect supervision system.This reform has achieved such outcomes as accessibility of the insured people to primary medical insurance,balance for the medical insurance fund,curbing of rapid rise of medical expenses,progress in the policy of first contact in the community health organization,promoting the development of the health system and raising satisfaction among the insured people year by year.
10.Clinical observation on rabeprazole combined with mosapride in treatment of reflux esophagitis
Chinese Journal of Primary Medicine and Pharmacy 2011;18(15):2063-2064
ObjectiveTo study the the efficacy and safety of joint rabeprazole mosapride treatment of reflux esophagitis(RE). Methods110 patients Confirmed by endoscopy reflux esophagitis were randomly divided into treatment group and control group 55 cases. Treatment group:oral rabeprazole 10mg, sooner or later, a second fasting taking each mosapride 5mg,3 times/day, fasting and a half hours to take; control group: omeprazole 20mg/day, taken before meals ,mosapride taking followed. 2 groups of patients were completed 6 weeks of treatment ,the clinical efficacy and safety were observed. ResultsThe clinical total effective rate of symptom relief( symptom improvement and endoscopic remission and mucosal lesions ) were 94.5% for the treatment group ( 52/55 ), control group 76.4% ( 42/55), the efficiency of the treatment group was superior in the control group ( P < 0.05 ). ConclusionRabeprazole joint mosapride treatment of reflux esophagitis could improve symptoms rapidly,and clinical efficacy was superior to omeprazole mosapride treatment of reflux esophagitis, and was safe and reliable.